The Executive Council is formulating the material for Menopause Counselling Certification courses for different levels of our membership.

In a Press Statement issue on behalf of the International Menopause Society (http://www.imsociety.org) on 24 July 2007, the President, Professor Amos Pines concludes that the new epidemiological data coming from the Kaiser Permanente study do have scientific merits, but may be confusing when interpreted for the lay public. Health-care providers should stay with the first-grade information coming from the WHI study when discussing this issue with their patients: breast-wise, in women younger than 60, HT (particularly estrogen-alone) is safe. Long-term use may be associated with a small increased risk, in the order of one extra case per 1000 women per year. Discontinuation of HT brings this risk back to the values for age-matched non-users after 3–5 years. Weighing the overall benefits and risks of HT in the younger postmenopausal population clearly favors the use of HT for symptomatic women.
 
The Executive Council is eager to update records of all our members. I urge members to update your details soonest with our new Secretariat (please refer to the new telephone number).
  
For members who want our help in holding health talks or organizing public forums to their own Societies or Clubs, please contact any of the Council Members for advice.
 
May God continue to bless you with health in the menopause.